Hiroshi Ishii

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Topics

Idiopathic Pulmonary Fibrosis

Interstitial Lung Disease

Clostridium Difficile

Top Venues

BMJ case reports

ERJ open research

Antibiotics (Basel, Switzerland)

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yoshiaki Kinoshita, Shota Takenaka, Kengo Takata, Takuhide Utsunomiya, Yohei Koide, Kenji Wada, Yuji Yoshida, Shota Nakashima, Hisako Kushima, Hiroshi Ishii
Platythorax increases residual volume/total lung capacity in idiopathic pleuroparenchymal fibroelastosis. ERJ open research 10 (4) (2024)
Yoshiaki Kinoshita, Shota Takenaka, Kengo Takata, Takuhide Utsunomiya, Yohei Koide, Kenji Wada, Yuji Yoshida, Shota Nakashima, Hisako Kushima, Hiroshi Ishii
Platythorax increases residual volume/total lung capacity in idiopathic pleuroparenchymal fibroelastosis. ERJ open research 10 (4) (2024)
Yota Yamada, Motoyasu Miyazaki, Hisako Kushima, Yukie Komiya, Akio Nakashima, Hiroshi Ishii, Osamu Imakyure
Impact of Nucleic Acid Amplification Test on Clinical Outcomes in Patients with Clostridioides difficile Infection. Antibiotics (Basel, Switzerland) 12 (3) (2023)
Kazuya Tsubouchi, Naoki Hamada, Shoji Tokunaga, Katsuyuki Ichiki, Shohei Takata, Hiroshi Ishii, Yasuhiko Kitasato, Masaki Okamoto, Satoru Kawakami, Kazuhiro Yatera, Masayuki Kawasaki, Masaki Fujita, Makoto Yoshida, Takashige Maeyama, Taishi Harada, Hiroshi Wataya, Ryo Torii, Masashi Komori, Yuichi Mizuta, Kazunori Tobino, Eiji Harada, Hidetake Yabuuchi, Yoichi Nakanishi, Isamu Okamoto
Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry. BMJ open respiratory research 10 (1) (2023)
Yota Yamada, Motoyasu Miyazaki, Hisako Kushima, Yukie Komiya, Akio Nakashima, Hiroshi Ishii, Osamu Imakyure
Impact of Nucleic Acid Amplification Test on Clinical Outcomes in Patients with Clostridioides difficile Infection. Antibiotics (Basel, Switzerland) 12 (3) (2023)
Motoyasu Miyazaki, Ryoko Yanagida, Akio Nakashima, Koichi Matsuo, Norihiro Moriwaki, Masanobu Uchiyama, Yota Yamada, Hitomi Hirata, Hisako Kushima, Yoshiaki Kinoshita, Hiroshi Ishii, Osamu Imakyure
Evaluation of Remdesivir for Mildly to Moderately Ill Patients with COVID-19: A Single-Arm, Single-Center, Retrospective Study. Medicina (Kaunas, Lithuania) 58 (8) (2022)
Yoshiaki Kinoshita, Hisako Kushima, Hiroshi Ishii
Idiopathic pleuroparenchymal fibroelastosis. BMJ case reports 15 (7) (2022)
Takuto Miyamura, Yoshiaki Kinoshita, Hisako Kushima, Hiroshi Mukae, Hiroshi Ishii
Lung involvement during the prediagnostic phase of idiopathic pleuroparenchymal fibroelastosis. ERJ open research 8 (2) (2022)
Hisako Kushima, Hiroshi Ishii, Yoshiaki Kinoshita, Yohei Koide, Yukie Komiya, Junko Kato, Mayumi Umehara, Miho Sakata, Motoyasu Miyazaki, Mikihiro Ikuta
The Limited Effect of a History of COVID-19 on Antibody Titers and Adverse Reactions Following BNT162b2 Vaccination: A Single-Center Prospective Study. Journal of clinical medicine 11 (18) (2022)
Hisako Kushima, Ryohei Sakamoto, Yoshiaki Kinoshita, Hiroshi Ishii
Tuberculous peritonitis. BMJ case reports 14 (10) (2021)
Yoshiaki Kinoshita, Takato Ikeda, Takuto Miyamura, Yusuke Ueda, Yuji Yoshida, Hisako Kushima, Masaki Fujita, Takashi Ogura, Kentaro Watanabe, Hiroshi Ishii
A proposed prognostic prediction score for pleuroparenchymal fibroelastosis. Respiratory research 22 (1) (2021)
Takato Ikeda, Yoshiaki Kinoshita, Hisako Kushima, Hiroshi Ishii
Extensive subcutaneous emphysema in severe asthma. BMJ case reports 14 (9) (2021)
Hisako Kushima, Toshiyuki Tsunoda, Taichi Matsumoto, Yoshiaki Kinoshita, Koichi Izumikawa, Senji Shirasawa, Masaki Fujita, Hiroshi Ishii
Effects of Aspergillus fumigatus Conidia on Apoptosis and Proliferation in an In Vitro Model of the Lung Microenvironment. Microorganisms 9 (7) (2021)
Hiroshi Ishii, Yoshiaki Kinoshita, Hisako Kushima, Nobuhiko Nagata, Kentaro Watanabe
The similarities and differences between pleuroparenchymal fibroelastosis and idiopathic pulmonary fibrosis. Chronic respiratory disease 16 (2020)
Hisako Kushima, Yoshiaki Kinoshita, Hiroshi Ishii, Masaki Fujita
Tattoo-induced systemic sarcoidosis. BMJ case reports 13 (8) (2020)
Takato Ikeda, Yoshiaki Kinoshita, Yusuke Ueda, Tomoya Sasaki, Hisako Kushima, Hiroshi Ishii
Physiological Criteria Are Useful for the Diagnosis of Idiopathic Pleuroparenchymal Fibroelastosis. Journal of clinical medicine 9 (11) (2020)
Yoshiaki Kinoshita, Hiroshi Ishii, Hisako Kushima, Takeshi Johkoh, Hidetake Yabuuchi, Masaki Fujita, Kazuki Nabeshima, Kentaro Watanabe
Remodeling of the pulmonary artery in idiopathic pleuroparenchymal fibroelastosis. Scientific reports 10 (1) (2020)
Hiroshi Ishii, Yoshiaki Kinoshita, Hisako Kushima, Takashi Ogura, Kentaro Watanabe
The upward shift of hilar structures and tracheal deviation in pleuroparenchymal fibroelastosis. Multidisciplinary respiratory medicine 14 (2019)
Hiroshi Ishii, Hisako Kushima, Yoshiaki Kinoshita, Masaki Fujita, Kentaro Watanabe
The serum KL-6 levels in untreated idiopathic pulmonary fibrosis can naturally decline in association with disease progression. The clinical respiratory journal 12 (9) (2018)
Hiroshi Ishii, Rikako Shima, Yoshiaki Kinoshita, Hisako Kushima
Marfan syndrome presenting with diffuse emphysematous change of the lung. BMJ case reports 2018 (2018)